PTEN negatively regulates neural stem cell self-renewal by modulating G 0 -G 1 cell cycle entry
Open accessThe DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Abstract
Previous studies have demonstrated that a small subpopulation of brain tumor cells share key characteristics with neural stem/progenitor cells in terms of phenotype and behavior. These findings suggest that brain tumors might contain “cancer stem cells” that are critical for tumor growth. However, the molecular pathways governing such stem cell-like behavior remain largely elusive. Our previous study suggests that the phosphatase and tensin homologue deleted on chromosome 10 ( PTEN ) tumor suppressor gene, one of the most frequently mutated genes in glioblastomas, restricts neural stem/progenitor cell proliferation in vivo . In the present study, we sought to determine the role of PTEN in long-term maintenance of stem cell-like properties, cell cycle entry and progression, and growth factor dependence and gene expression. Our results demonstrate an enhanced self-renewal capacity and G 0 -G 1 cell cycle entry and decreased growth factor dependency of Pten null neural/stem progenitor cells. Therefore, loss of PTEN leads to cell physiological changes, which collectively are sufficient to increase the pool of self-renewing neural stem cells and promote their escape from the homeostatic mechanisms of proliferation control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PTEN could activate FOXO activity and inhibit the insulin/IGF pathway, suppressing neurogenesis [28–31].”
From M2 microglia-derived small extracellular vesicles modulate NSC fate after ischemic stroke via miR-25-3p/miR-93-5p-TGFBR/PTEN/FOXO3 axis (2025) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Activation of the insulin/IGF pathway increases NSC proliferation and self-renewal [28].”
From M2 microglia-derived small extracellular vesicles modulate NSC fate after ischemic stroke via miR-25-3p/miR-93-5p-TGFBR/PTEN/FOXO3 axis (2025) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“loss of the negative regulator PTEN was shown to result in sustained proliferative potential of NSC (Groszer et al., 2006; Groszer et al., 2001).”
From FoxOs Cooperatively Regulate Diverse Pathways Governing Neural Stem Cell Homeostasis (2009) · cites this paper as Groszer et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 4,482
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., & Vescovi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Research works printed but not linked: 3
- Li, J., Simpson, L., Takahashi, M., Miliaresis, C., Myers, M. P., Tonks, N. & Parsons, R. (1998) Cancer Res. 58, 5667–5672. [PubMed] [Google Scholar]
- Marino, S., Krimpenfort, P., Leung, C., van der Korput, H. A., Trapman, J., Camenisch, I., Berns, A. & Brandner, S. (2002) Development (Cambridge, U.K.) 129, 3513–3522. [DOI] [PubMed] [Google Scholar]
- Yue, Q., Groszer, M., Gil, J. S., Berk, A. J., Messing, A., Wu, H. & Liu, X. (2005) Development (Cambridge, U.K.) 132, 3281–3291. [DOI] [PubMed] [Google Scholar]
Cited by
Items 301–314 of 314
Rosenzweig, S. A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733388356.793572339
(2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800165-3.00023-0
PTEN regulates actin filaments to shape cell cortex architecturePreprint
Ho, K., Patel, S. S., Sullivan, E., Chang, A., Lin, G. H., Lv, M., Fan, X., Naufal, E. R., & Shen, W. H. (2023) · Research Square · doi:10.21203/rs.3.rs-2375922/v1
THE ROLE OF NADPH OXIDASE 2 IN AXON GUIDANCE DURING ZEBRAFISH VISUAL SYSTEM DEVELOPMENT
Terzi, A. (2020) · Purdue e-Pubs (Purdue University System) · doi:10.25394/pgs.12743375
Kang, S. C., Jaini, R., Hitomi, M., Lee, H., Sarn, N., Thacker, S., & Eng, C. (2020) · Figshare · doi:10.6084/m9.figshare.12414263
Neural stem cells plasticity and differentiation
Flici, H. (2012) · theses.fr (ABES) · doi:10.70675/43448416z369fz4b50zb0d2z985989dbb1ed
Daynac, M. (2013) · theses.fr (ABES) · doi:10.70675/a50217c9za90dz489azbb31z9cd4f08fa502
“La délétion de Pten favorise l’auto-renouvellement des CSN en modulant positivement la transition G0-G1 et l’entrée en G1 des CSN (Groszer et al., 2006).”
BackgroundBui, A. T. (2016) · theses.fr (ABES) · doi:10.70675/f5bf5bd9z156az422ezbb82zd0edb6d2409b
“Il est à noter que PTEN est aussi impliquée dans le contrôle de la quiescence des cellules souches hématopoïétiques et des cellules souches neurales (Groszer et al., 2006; Zhang et al., 2006a).”
Sulava, S., Jalli, D. R., Chawla, S., Senapati, S., & Alone, D. P. (2026) · Cancer Cell International · doi:10.1186/s12935-025-04148-4
“…such as Phosphatidylinositol-4 , 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) mutations and Phosphatase and Tensin Homolog ( PTEN) loss [44] lead to persistent AKT signaling, contributing to uncontrolled proliferation, survival, and metabolic adaptation, amounting to an aggressive…”
Caenorhabditis elegans DAF-18/PTEN non-autonomously prevents tumors by enhancing calcium sensitivityPreprint
Deng, J., Mbieda, I. C. D., Chaudhari, A. M., Gagné, O., Roy, V., Martel, P.-O., Simard, M. J., & Narbonne, P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.31.748322
“Indeed, and although there is overwhelming evidence that the loss of PTEN in stem cells confers a cell autonomous proliferative advantage (Groszer et al. 2006; Wang et al. 2006; Hill and Wu 2009; Magee et al. 2012), our results emphasize that the generation of hamartoma-like tumors may require…”
mTOR-Mediated Neuron–Cancer Interactions
Nyarkoh, J. K., Wolan, M. J., & Feliciano, D. M. (2026) · Kinases and Phosphatases · doi:10.3390/kinasesphosphatases4030024
Mihaliak, A. M. (2010) · eScholarship@UMassChan · doi:10.13028/j41x-ab26
“PTEN deficiency mediates enhanced self-renewal by promoting cells to enter the cell cycle from G0 [61], as well as accelerating the G1 to S cell cycle transition [62].”
Novel Regulation of the Cell Cycle During Cell Fate Decisions in the Central Nervous System
Lubanska, D. (2013) · Scholarship at UWindsor (University of Windsor)
Metadata
- Authors
- Groszer, M., Erickson, R., Scripture-Adams, D. D., Dougherty, J. D., Le Belle, J., Zack, J. A., Geschwind, D. H., Liu, X., Kornblum, H. I., & Wu, H.
- Affiliations
- University of California, Los Angeles (US)
- Departments of Molecular and Medical Pharmacology, Pathology and Laboratory Medicine, Microbiology, Immunology, and Molecular Genetics, and Pediatrics, and Department of Neurology and The Neuropsychiatric Institute, David Geffen School of Medicine, University of California, Los Angeles, CA 90095
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-12-22
- Volume
- 103
- Issue
- 1
- Pages
- 111-116
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1325011
- OpenAlex
- W2166321551
- Cited by
- 306
- References
- 46
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 4 · 2023: 9 · 2022: 3 · 2021: 9 · 2020: 19 · 2019: 9 · 2018: 7 · 2017: 11 · 2016: 12 · 2015: 14 · 2014: 19 · 2013: 16 · 2012: 16
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Science Foundation
- Amgen
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (65756)
- National Institutes of Health
- U.S. Public Health Service (65756)
- National Institute of Mental Health
- National Institute of Neurological Disorders and Stroke (NS38439)
- Jonsson Comprehensive Cancer Center
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- PTEN, neural stem cells, self-renewal, cell cycle progression, growth factor dependence, glioblastoma, cancer stem cells, neural stem/progenitor cells, tumor suppressor, PTEN knockout
- MeSH terms
- Animals, Cell Cycle, Cell Differentiation, Cerebral Cortex, Stem Cells, Fibroblast Growth Factor 2, Gene Deletion, Oligonucleotide Array Sequence Analysis, Cell Proliferation, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.